Stille AB (OSTO:STIL) Research & Development: kr0.0 Mil (TTM As of Mar. 2026)


OSTO:STIL Stille AB OSTO:STIL
98 GF Score
Price kr244.50
GF Value kr235.77
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Stille AB Research & Development?

Stille AB OSTO:STIL -1.01% 98 Research & Development is kr0.0 Mil as of Mar. 2026. GuruFocus rates OSTO:STIL with a GF Score™ of 98/100 and a GF Value™ of kr235.77 (Fairly Valued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Stille AB's Research & Development for the three months ended in Mar. 2026 was kr0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.0 Mil.

Stille AB  (OSTO:STIL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Stille AB Research & Development Related Terms

Stille AB Research & Development Historical Data

* Premium members only.

The historical data trend for Stille AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stille AB Research & Development Chart

Stille AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Stille AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:STIL
98GF Score
Stille AB OSTO:STIL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stille AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.0 Mil mean?
Stille AB (OSTO:STIL) has a Research & Development of kr0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Stille AB and its competitors.
Is Stille AB's Research & Development too high?
Stille AB's current Research & Development is kr0.0 Mil. Overall, Stille AB has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stille AB's Research & Development compare to ISRG and BDX?
Stille AB's Research & Development of kr0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Stille AB and its competitors. Stille AB's current Research & Development is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stille AB stock overvalued right now?
Based on GuruFocus' analysis, Stille AB (OSTO:STIL) is currently considered Fairly Valued. The stock's GF Value™ is kr235.77, compared to a current price of kr244.50 — trading 3.7% above its estimated fair value. The current Research & Development is kr0.0 Mil. Stille AB's overall GF Score™ is 98/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Stille AB (OSTO:STIL), the current Research & Development is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stille AB (OSTO:STIL) Overvalued in 2026?

Based on GuruFocus' analysis, Stille AB stock appears to be overvalued. The current stock price of kr244.50 is trading 3.7% above its estimated GF Value™ of kr235.77. GuruFocus considers Stille AB to be Fairly Valued.

Key valuation signals for OSTO:STIL:

  • Research & Development: kr0.0 Mil
  • GF Value™: kr235.77 vs. price of kr244.50 (3.7% above fair value)
  • GF Score™: 98/100 with 4 warning signs

No single metric tells the full story. See the OSTO:STIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stille AB Business Description

Other Exchanges 8R6:Germany
Address Ekbacken 11, Torshalla, SWE, 644 30
Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
98GF Score

Get the complete analysis for OSTO:STIL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr244.50
Price
kr235.77
GF Value